The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.

Elevation of circulating GH acts to feed back at the level of the hypothalamus to decrease GH-releasing hormone (GHRH) and increase somatostatin (SRIF) production. In the rat, GH-induced changes in GHRH and SRIF expression are associated with changes in pituitary GHRH receptor (GHRH-R), GH secretagogue receptor (GHS-R), and SRIF receptor subtype messenger RNA (mRNA) levels. These observations suggest that GH regulates its own synthesis and release not only by altering expression of key hypothalamic neuropeptides but also by modulating the sensitivity of the pituitary to hypothalamic input, by regulating pituitary receptor synthesis. To further explore this possibility, we examined the relationship between the expression of hypothalamic neuropeptides [GHRH, SRIF, and neuropeptide Y (NPY)] and pituitary receptors [GHRH-R, GHS-R, and SRIF receptor subtypes (sst2 and sst5)] in two mouse strains with alterations in the GH-axis; the GH receptor/binding protein gene-disrupted mouse (GHR/BP-/-) and the metallothionein promoter driven human GHRH (MT-hGHRH) transgenic mouse. In GHR/BP-/- mice, serum insulin-like growth factor I levels are low, and circulating GH is elevated because of the lack of GH negative feedback. Hypothalamic GHRH mRNA levels in GHR/BP-/- mice were 232 +/- 20% of GHR/BP+/+ littermates (P < 0.01), whereas SRIF and NPY mRNA levels were reduced to 86 +/- 2% and 52 +/- 3% of controls, respectively (P < 0.05; ribonuclease protection assay). Pituitary GHRH-R and GHS-R mRNA levels of GHR/BP-/- mice were elevated to 275 +/- 55% and 319 +/- 68% of GHR/BP+/+ values (P < 0.05, respectively), whereas the sst2 and sst5 mRNA levels did not differ from GHR/BP intact controls as determined by multiplex RT-PCR. Therefore, in the absence of GH negative feedback, both hypothalamic and pituitary expression is altered to favor stimulation of GH synthesis and release. In MT-hGHRH mice, ectopic hGHRH transgene expression elevates circulating GH and insulin-like growth factor I. In this model of GH excess, endogenous (mouse) hypothalamic GHRH mRNA levels were reduced to 69 +/- 6% of nontransgenic controls, whereas SRIF mRNA levels were increased to 128 +/- 6% (P < 0.01). NPY mRNA levels were not significantly affected by hGHRH transgene expression. Also, MT-hGHRH pituitary GHRH-R and GHS-R mRNA levels did not differ from controls. However, sst2 and sst5 mRNA levels in MT-hGHRH mice were increased to 147 +/- 18% and 143 +/- 16% of normal values, respectively (P < 0.05). Therefore, in the presence of GH negative feedback, both hypothalamic and pituitary expression is altered to favor suppression of GH synthesis and release.

[1]  J. Kamegai,et al.  Expression of Growth Hormone Receptor Gene in Rat Hypothalamus , 1993, Journal of neuroendocrinology.

[2]  M. Korbonits,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other , 2022 .

[3]  J. Kamegai,et al.  Growth hormone induces expression of the c-fos gene on hypothalamic neuropeptide-Y and somatostatin neurons in hypophysectomized rats. , 1994, Endocrinology.

[4]  R. Kineman,et al.  Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis. , 2000, Endocrinology.

[5]  J. Epelbaum,et al.  Characterization of Somatostatin Receptor Subtypes in Mammalian Pituitary , 1998, Annals of the New York Academy of Sciences.

[6]  S. Asa,et al.  Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice. , 2000, The American journal of pathology.

[7]  G. Aguilera,et al.  Actions of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary , 1984, Molecular and Cellular Endocrinology.

[8]  G. Morel,et al.  Restricted Presence of the Growth Hormone-Releasing Hormone Receptor to Somatotropes in Rat and Human Pituitaries , 1999, Neuroendocrinology.

[9]  R. Kineman,et al.  The tyrosine hydroxylase-human growth hormone (GH) transgenic mouse as a model of hypothalamic GH deficiency: growth retardation is the result of a selective reduction in somatotrope numbers despite normal somatotrope function. , 1996, Endocrinology.

[10]  K. Christov,et al.  p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation , 2000, Oncogene.

[11]  I. Robinson,et al.  Intrahypothalamic Growth Hormone Feedback: From Dwarfism to Acromegaly in the Rat. , 1997, Endocrinology.

[12]  P. Chomczyński,et al.  Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse. , 1989, Molecular endocrinology.

[13]  T. Wagner,et al.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Frohman,et al.  Immunohistochemical analysis of human growth hormone-releasing hormone gene expression in transgenic mice. , 1989, Endocrinology.

[15]  R. Hammer,et al.  Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth , 1985, Nature.

[16]  Y. Patel.  Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.

[17]  D. Clemmons,et al.  Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. , 2000, Endocrinology.

[18]  High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. , 2000, Endocrinology.

[19]  Enjalbert,et al.  Expression Of Functional Growth Hormone Secretagogue Receptors In Human Pituitary Adenomas: Polymerase Chain Reaction, Triple In‐situ Hybridization And Cell Culture Studies1 , 1999, Journal of neuroendocrinology.

[20]  A. Bartke,et al.  Pituitary and testicular function in growth hormone receptor gene knockout mice. , 1999, Endocrinology.

[21]  P. Gaudreau,et al.  Differential in Vivo Regulation of the Pituitary Growth Hormone-Releasing Hormone (GHRH) Receptor by GHRH in Young and Aged Rats. , 1999, Endocrinology.

[22]  R. Kineman,et al.  Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. , 1999, Endocrinology.

[23]  P. Chomczyński,et al.  Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in rat hypothalamus. , 1988, Molecular endocrinology.

[24]  E. Hewlett,et al.  Human pancreatic tumor growth hormone-releasing factor stimulates anterior pituitary adenylate cyclase activity, adenosine 3',5'-monophosphate accumulation, and growth hormone release in a calmodulin-dependent manner. , 1984, Endocrinology.

[25]  J. Bertherat,et al.  Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat. , 1993, The Journal of clinical investigation.

[26]  R. Kineman,et al.  Growth Hormone-Dependent Regulation of Pituitary GH Secretagogue Receptor (GHS-R) mRNA Levels in the Spontaneous Dwarf Rat , 1998, Neuroendocrinology.

[27]  P. Chomczyński,et al.  Effects of thyroid hormone deficiency and replacement on rat hypothalamic growth hormone (GH)-releasing hormone gene expression in vivo are mediated by GH. , 1990, Molecular endocrinology.

[28]  R G Smith,et al.  Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. , 1998, Science.

[29]  M. Stoler,et al.  Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. , 1997, The American journal of pathology.

[30]  L. Frohman,et al.  Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. , 1993, Endocrinology.

[31]  R. Steiner,et al.  Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. , 1996, Endocrinology.

[32]  H. Nogami,et al.  Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction. , 1990, Endocrinology.

[33]  M. Skinner,et al.  Growth hormone secretagogue receptor expression in human pituitary tumors. , 1998, The Journal of clinical endocrinology and metabolism.

[34]  R. Kineman,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Hypothalamic/Pituitary-Axis of the Spontaneous Dwarf Rat: Autofeedback Regulation of Growth Hormone (GH) Includes Suppression of GH Releasing-Hormone Receptor Messenger Ribonucleic Acid* , 2022 .

[35]  J. Kamegai,et al.  Effect of insulin-like growth factor-I on growth hormone-releasing factor receptor expression in primary rat anterior pituitary cell culture , 1999, Neuroscience Letters.

[36]  R. Hammer,et al.  Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. , 1988, Molecular endocrinology.

[37]  B. Burguera,et al.  Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat. , 1993, Neuroendocrinology.